Table 1 Baseline characteristics of study participants
T2DM group | non-T2DM group | P-value | |
|---|---|---|---|
No. of participants | 177 | 136 | |
Age (years) | 65.96 ± 9.69 | 66.21 ± 9.64 | > 0.05 |
HbA1C (%) | 8.00 (7.00, 9.30) | None | NA |
Diabetic duration (years) | 11.50 ± 5.04 | None | NA |
Treatment | |||
Insulin | 42 (23.73%) | None | NA |
Insulin and Oral anti-diabetic agents, n (%) | 55 (31.07%) | None | NA |
Oral anti-diabetic agents (no thiazolidinediones), n (%) | 80 (45.20%) | None | NA |